Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020)

Author:

Flick Holger,Arns Britt-Madelaine,Bolitschek Josef,Bucher Brigitte,Cima Katharina,Gingrich Elisabeth,Handzhiev Sabin,Hochmair Maximilian,Horak Fritz,Idzko Marco,Jaksch Peter,Kovacs Gabor,Kropfmüller Roland,Lamprecht Bernd,Löffler-Ragg Judith,Meilinger Michael,Olschewski Horst,Pfleger Andreas,Puchner Bernhard,Puelacher Christoph,Prior Christian,Rodriguez Patricia,Salzer Helmut,Schenk Peter,Schindler Otmar,Stelzmüller Ingrid,Strenger Volker,Täubl Helmut,Urban Matthias,Wagner Marlies,Wimberger Franz,Zacharasiewicz Angela,Zwick Ralf Harun,Eber Ernst

Abstract

SummaryThe coronavirus disease 2019 (COVID-19) pandemic is currently a challenge worldwide. In Austria, a crisis within the healthcare system has so far been prevented. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV‑2 infections, should continue to be based on evidence-based CAP guidelines during the pandemic; however, COVID-19 specific adjustments are useful. The treatment of patients with chronic lung diseases has to be adapted during the pandemic but must still be guaranteed.

Funder

Medical University of Graz

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Reference117 articles.

1. Coronavirus disease 2019 (COVID-19) Situation Report – 97; status 08.05.2020: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

2. Rapid Risk Assessment: Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK—ninth update: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-rapid-risk-assessment-coronavirus-disease-2019-ninth-update-23-april-2020.pdf. Accessed 27 April 2020

3. Garg S, Kim L, Whitaker M, O’Halloran A, Cummings C, Holstein R, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed Coronavirus disease 2019—COVID-NET, 14 states, march 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–64. https://doi.org/10.15585/mmwr.mm6915e3.

4. COVID-19 situation update for the EU/EEA and the UK, as of 9 May 2020: https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea. Accessed 9 May 2020.

5. EuroMOMO. European Mortality Bulletin. 2020. https://www.euromomo.eu/bulletins/2020-18/ and https://www.euromomo.eu/graphs-and-maps/. Accessed 9 May 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3